Why MediWound Is Trading Lower By Around 18%, Here Are 48 Stocks Moving In Thursday's Mid-Day Session
Why MediWound Is Trading Lower By Around 18%, Here Are 48 Stocks Moving In Thursday's Mid-Day Session
Gainers
Spero Therapeutics, Inc. (NASDAQ:SPRO) rose 150% to $2.0508 after the company announced it has entered into an exclusive license agreement with GSK for Spero's late-stage antibiotic asset, tebipenem HBr. Spero Therapeutics will receive $66 million upfront, with potential for future milestone payments, and tiered royalties. HeartBeam, Inc. (NASDAQ:BEAT) shares gained 34% to $2.12 after dropping 16% on Wednesday. Heartbeam recently announced its patent for a 12-lead electrocardiogram patch monitor intended for detection of acute coronary syndrome and cardiac arrhythmia was issued by the USPTO. ShiftPixy, Inc. (NASDAQ:PIXY) shares jumped 32.4% to $18.09. ShiftPixy, on Wednesday, announced pricing of $5 million private placement. Inventiva...
译文内容由第三方软件翻译。
风险及免责提示
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧